Clinical Trial Update: A Phase II Trial to Assess Hemodynamic Effects of Istaroxime in Pts With Worsening HF and Reduced LV Systolic Function [Phase 2]

View source ↗

Summary

A Phase II trial assessing the hemodynamic effects of istaroxime in patients with worsening heart failure and reduced left ventricular systolic function has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Istaroxime (istaroxime)

Snippet

Sponsor: sigma-tau i.f.r. S.p.A. | Conditions: Heart Failure | Phase 2 | Status: COMPLETED